aamc.org does not support this web browser.

Advocacy & Policy

The Association of American Medical Colleges (AAMC) works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Through policies that affect health care delivery, research, education, health equity, and more, the federal government is a key partner in sustaining the vitality of the nation’s academic medicine ecosystem, which is essential to improving the health of all. Learn more about the AAMC’s priorities for the 118th Congress.

Supreme Court building facade in Washington, DC

AAMC Encouraged by SCOTUS Decision on Mifepristone Access

The AAMC issued a statement regarding the SCOTUS decision on a case about mifepristone access.

learn more

AAMC Policy and Priorities

microscope

Research

AAMC-member institutions endeavor to prepare a diverse medical research workforce and champion an environment where medical discovery can flourish. This strong commitment is key to innovation that benefits patients.

Explore Research Priorities

doctor in a coat

Clinical Care

AAMC-member teaching hospitals and faculty physicians cultivate and provide high-quality health care, especially for complex and vulnerable patients -- many of whom are unable to receive care elsewhere.

Explore Clinical Care Priorities

Doctor talking to mother and son at community outreach program

Investing in Healthier Communities

Academic medical centers serve at the crossroads of community health, health equity, and population health and are actively working to prevent and address persistent public health challenges.

Explore Healthier Communities

two doctors

Workforce

AAMC-member medical schools and teaching hospitals play a crucial role in preparing future physicians who help create a healthier future for all with innovative graduate medical education.

Explore Workforce Priorities

Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe

Find Advocacy & Policy Content

  • Recent
  • Relevance

Filter Results

Date
Custom Date Range
Date format: MM/DD/YYYY
Topic
41 - 50 of 77 results
Prescription Drugs Translational Research
Washington Highlights

Federal officials testified before the Senate Health, Education, Labor, and Pensions (HELP) Committee on the COVID-19 response on June 16.

  • June 17, 2022
Pipette adding sample to petri dish with DNA profiles
Washington Highlights

On June 15, the Supreme Court ruled in favor of 340B hospitals in a case challenging the reduction of Medicare reimbursement rates for outpatient drugs.

  • June 17, 2022
Someone writing a prescription
Testimony & Correspondence

The AAMC joined nearly 50 stakeholders in a letter to House Appropriations Committee leaders outlining the importance of large animal research

  • June 13, 2022
  • PDF
Washington Highlights

On June 7, the House of Representatives held a special order commemorating the 30th anniversary of the 340B Drug Pricing Program.

  • June 10, 2022
pill bottles
Washington Highlights

The Centers for Medicare and Medicaid Services (CM) issued a new HCPCS code for the outpatient administration of IV Remdesivir on Jan. 7, 2022.

  • Jan. 7, 2022
A female doctor talking with man and woman patients in an office or clinic.
Washington Highlights

The Centers for Medicare & Medicaid Services (CMS) rescinded the interim final rule that would have reduced Medicare reimbursement for certain Part B drugs.

  • Jan. 7, 2022
Washington Highlights

The House Energy and Commerce health subcommittee held a hearing on the future of biomedical research featuring witnesses from academic medicine.

  • Dec. 10, 2021
A scientist experimented in the laboratory
Washington Highlights

HRSA sent letters to pharmaceutical manufacturers who said they’d no longer supply 340B drugs dispensed via contract pharmacies at or below 340B ceiling prices

  • Sept. 24, 2021
Someone writing a prescription
Washington Highlights

The Department of Health and Human Services (HHS) announced on Sept. 10 that it will distribute $25.5 billion from the Provider Relief Fund.

  • Sept. 17, 2021
HHS building
Washington Highlights

A new drug pricing proposal from the HHS identifies three guiding principles to lower drug costs.

  • Sept. 10, 2021
HHS building
The east side of the US Capitol in the early morning.

AAMC Champion of Academic Medicine Award

This award recognizes members of Congress and staff for extraordinary leadership in support of the academic medicine community.

Learn more

Advocacy Coalitions

The Ad Hoc Group for Medical Research supports enhancing the federal investment in the biomedical, behavioral, and population-based research conducted and supported by the NIH.

The GME Advocacy Coalition (GMEAC) is a group of organizations dedicated to the expansion and preservation of Medicare-supported graduate medical education.

The HPNEC advocates for continued support for the health professions and nursing workforce development programs critical to providing continued services to underserved and minority communities.

FOVA is a diverse coalition representing national academic, medical, and scientific societies; voluntary health and patient advocacy groups; and veteran-focused associations.

Questions for the Office of Government Relations?

Email Us
AAMC Action

AAMC Action – Let’s Raise Our Voices Together

We are a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us